Clinical Trials · NCT07685834

Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss

Active Not RecruitingN/ATirzepatide (Investigational)
Phase
N/A
Recruitment status
Active Not Recruiting
Sponsor
Sofwave Medical LTD
Enrollment
30
Start date
Feb 2026
Locations
1 site, Canada
Primary endpoint
Improvement in the appearance of lax skin
View Tirzepatide compound reference